from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1220c/-

LFCtreatmentdescriptionclass of inhibitor

-0.319

Amikacinug/mL Amikacintranslation

-0.673

Cap5-10ug/mL Capreomycintranslation

-0.807

Rox10-50 ug/mL Roxithromycintranslation

0.221

SM2-5 ug/mL Streptomycintranslation

0.073

Tet5-10 ug/mL Tetracyclinetranslation

-0.260

Rif0.2-5ug/mL Rifampicintranscription

0.486

Rifp0.1-0.5ug/mL Rifapentinetranscription

-3.105

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.005

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.507

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.506

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.510

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.087

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.418

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.510

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.731

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.684

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.478

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.448

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.829

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.096

KCN5-20 ug/mL Potassium cyaniderespiration

-0.217

NaN30.2-2 mM Sodium aziderespiration

-0.515

Nigericin50 uM Nigericinrespiration

0.606

TRC10-150 ug/mL Triclosanrespiration

-0.942

TRZ10-25 ug/mL Thioridazinerespiration

-2.139

Valinomycin0.5-10 uM Valinomycinrespiration

-0.876

ZnSO42 mM ZnSO4respiration

0.137

menadione6-10 ug/mL Menadionerespiration

-0.507

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.387

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.746

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.307

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.378

NRP_1Non-replicating persistence stage 1dosRassociated

0.817

Amp0.2mg/mL AmpicillincellWall

0.650

Cephalexin20-100 ug/mL CephalexincellWall

-0.118

Cerulenin0.32-5 ug/mL CerulenincellWall

0.376

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.328

EMB10-20 ug/mL EthambutolcellWall

0.076

Eta12-40 ug/mL EthionamidecellWall

0.361

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.281

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.246

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.352

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.647

BZA0.12 mg/mL BenzamidearomaticAmides

0.487

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.750

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.020

H2O24 mM hydrogen peroxideDNAdamaging

-0.069

Levo10 ug/mL LevofloxacinDNAdamaging

0.282

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.166

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.006

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.012

UVUV-irradiationDNAdamaging

0.662

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.479

Antimycin12.5-50 ug/mL Antimycin A?

0.196

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.001

PA_110-50 ug/mL Antitubercular compound PA-1?

0.006

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.551

PA8240.2-2 ug/mL PA-824?

1.467

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.371

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.685

Verapamil50 uM Verapamil?

-0.270

mercaptoethanol2 mM 2-Mercaptoethanol?

0.123

methoxatin10-20 ug/mL Methoxatin?